Mentor, Ohio-based STERIS plc (STE) provides infection prevention products and services in the United States and internationally. The company has a market cap of $23.1 billion and operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences, and offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing systems and tracking products, endoscopy accessories, instruments, and more.
Shares of STERIS have lagged behind the broader market over the past year, declining 4.9% compared to the S&P 500 Index’s ($SPX) 18.7% surge. Moreover, in 2026, the stock has fallen by nearly 6.7%, also underperforming SPX’s 12.2% gain.